Archives

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
Will these five travel stocks weather the Covid-19 threat in 2022?
Consumer Stocks

Will these five travel stocks weather the Covid-19 threat in 2022?

Highlights Marriott International (NASDAQ: MAR) logged revenue of US$3.94 billion in Q3, FY21. American Airlines Group Inc. (NASDAQ: AAL) CEO Doug Parker will retire in March 2022. The revenue of Expedia Group, Inc. (NASDAQ: EXPE) jumped 97% Y...

Why did Dare Bioscience (DARE) stock jump Wednesday?
Healthcare Stocks

Why did Dare Bioscience (DARE) stock jump Wednesday?

Highlights Dare Bioscience Inc. (NASDAQ: DARE) received FDA approval for a new drug on Tuesday. Dare Bioscience’s stock price rose over 61% YTD. Its Xaciato drug is used in treating bacterial vaginosis in females. Shares of Dare Bio...

Grove Collaborative to go public in merger with Branson-backed SPAC
IPO

Grove Collaborative to go public in merger with Branson-backed SPAC

Highlights Grove said it would raise about US$87 million through PIPE (private investment in public equity) linked to the merger. The San Francisco-based startup Grove plans to use the proceeds to develop innovative products for eco-friendly h...

Cingulate Inc (CING) IPO: How to buy the stock?
IPO

Cingulate Inc (CING) IPO: How to buy the stock?

Highlights Cingulate is offering 4,166,666 shares of its common stock and warrants. The offering price is US$6 per share. The gross proceeds from the offering are expected to be around US$25 million. Biopharmaceutical company Cingulate In...

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.